Avance Clinical Signs MOU with Mid-Ship Biomedical to Strengthen Global Clinical Research Collaboration
Avance Clinical Signs MOU with Mid-Ship Biomedical to Strengthen Global Clinical Research Collaboration
Search results
We found 34 results for: “preclinical”
Avance Clinical Sponsors 2025 Citeline Awards in Boston
Avance Clinical is proud to sponsor the 2025 Citeline Awards, set to take place in Boston in May 2025. This prestigious event, now in its 9th year, celebrates excellence in clinical trial design, technological advancements, and the outstanding achievements of individuals, departments, teams, or organizations ...
Meet us at the 12th Annual OCT Southern California 2024
Avance Clinical is thrilled to be exhibiting at the 12th Annual Outsourcing in Clinical Trials Southern California 2024, held on September 24-25 at the Hyatt Regency La Jolla at Aventine, San Diego.
Unveiling the Potential of Psychedelic Therapies: Key Insights for Biotech Decision Makers
The rapidly evolving field of psychedelic therapies offers a promising frontier for medical research, particularly in treating mental health and neurodegenerative diseases.
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs
Avance Clinical is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs.
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea – Seoul Office Announced at BIO Korea 2024
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open new clinical operations in Seoul, South Korea.
Asia
Avance Clinical is proud to announce the opening of our new operations in Seoul, addressing the growing demand from US biotechs and CRO partners for access to South Korea’s scientific excellence and diverse patient populations. This expansion underscores our commitment to providing a global pathway ...
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
Oragenics, Inc. (NYSE American: OGEN), a pioneer in developing innovative intranasal pharmaceuticals for neurological disorders, today announced a partnership with Avance Clinical, a leading Contract Research Organization (CRO), to conduct a Phase II clinical trial in Australia
Mike Watson
Mike is an experienced business development consultant, residing in North Carolina, US. Mike has been in the clinical space for over 13 years with experience in preclinical and clinical (Phase I-IV). Mike also has a thorough understanding of the Australian R & D Tax Incentive ...
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend World Vaccine Congress in Washington DC (April 1-4, 2024) and share the latest clinical trial client news including the Uvax Bio announcement. (Booth #267)